All News

    Phase 2 Trial of Firi-Cel CAR T-Cell Therapy Discontinued in Lymphoma

    February 12th 2025, 10:00pm

    Article

    The FIRCE-1 trial investigating the CAR T-cell therapy firi-cel in relapsed/refractory large B-cell lymphoma has been discontinued.

    GI Bleeding Significantly Impacts GIST Treatment Outcomes

    February 12th 2025, 8:00pm

    Article

    The prognosis of patients with gastrointestinal stromal tumors is significantly impacted by gastrointestinal bleeding.

    Moving Slower and Slower After Myelodysplastic Syndrome

    February 12th 2025, 6:00pm

    Article

    I have been frustrated lately by my increasing slowness following an blood cancer diagnosis, which has become noticeable to others.

    Empowering Patients and Advocating For Yourself After Cervical Cancer

    February 12th 2025, 5:00pm

    Video

    Dr. Ritu Salani discusses how patients with cervical cancer can advocate for their health and collaborate with their medical team to ensure the best care.

    FDA Approves Adcetris With Revlimid and Rituxan For R/R LBCL

    February 12th 2025, 3:16pm

    Article

    The FDA has approved Adcetris plus Revlimid and Rituxan in adults with relapsed or refractory large B-cell lymphoma.

    An Expert Explains the Enhertu Approval in HER2-Low and -Ultralow Breast Cancer

    February 12th 2025, 2:00pm

    Video

    Dr. Debu Tripathy discusses the FDA approval of Enhertu in unresectable or metastatic hormone receptor HR+, HER2-low or -ultralow breast cancer.

    Test May Predict Likelihood of Bladder Cancer Upstaging

    February 11th 2025, 10:00pm

    Article

    The Decipher Bladder Genomic Subtyping Classifier found that patients with luminal tumors may have less aggressive disease.

    Breaking Down The Importance of Targeted Therapies in Colorectal Cancer Care

    February 11th 2025, 8:00pm

    Video

    Dr. Suneel Kamath discusses the ALASCCA study in colorectal cancer and highlighted the importance of next-generation sequencing and testing.

    Unexpected Support in Tough Times With Multiple Myeloma

    February 11th 2025, 6:00pm

    Article

    Throughout my experience with multiple myeloma, I was humbled by the unexpected support and kindness shown to me.

    Explaining KRAS Mutations For Patients With Colorectal Cancer

    February 11th 2025, 5:00pm

    Video

    Dr. Marwan G. Fakih explains that KRAS mutations, found in 45% of patients with colorectal cancer, include the rare KRAS G12C mutation, leading to Lumakras approval.